» Articles » PMID: 29459868

Characteristics of Infection Immunity Regulated by to Maintain Chronic Infection in the Brain

Overview
Journal Front Immunol
Date 2018 Feb 21
PMID 29459868
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

To examine the immune environment of chronic infection in the brain, the characteristics of infection-immunity (premunition) in infection with . strain ME49 were investigated for 12 weeks postinfection (PI). The results showed that neuronal cell death, microglia infiltration and activation, inflammatory and anti-inflammatory cytokine expression, Stat1 phosphorylation, and microglia activation and inflammatory gene transcripts related to M1 polarization in the brain were increased during the acute infection (AI) stage (within 6 weeks PI), suggesting that innate and cellular inflammatory response activation and neurodegeneration contributed to excessive inflammatory responses. However, these immune responses decreased during the chronic infection (CI) stage (over 6 weeks PI) with reductions in phosphorylated STAT1 (pSTAT1) and eosinophilic neurons. Notably, increases were observed in transcripts of T-cell exhaustion markers (TIM3, LAG3, KLRG1, etc.), suppressor of cytokines signaling 1 protein (SOCS1), inhibitory checkpoint molecules (PD-1 and PD-L1), and Arg1 from the AI stage (3 weeks PI), implying active immune intervention under the immune environment of M1 polarization of microglia and increases in inflammatory cytokine levels. However, when BV-2 microglia were stimulated with lysate antigens (strain RH or ME49) , nitrite production increased and urea production decreased. Furthermore, when BV-2 cells were infected by tachyzoites (strain RH or ME49) , nitric oxide synthase and COX-2 levels decreased, whereas Arg1 levels significantly increased. Moreover, Arg1 expression was higher in ME49 infection than in RH infection, whereas nitrite production was lower in ME49 infection than in RH infection. Accordingly, these results strongly suggest that immune triggering of antigens induces M1 polarization and activation of microglia as well as increase NO production, whereas . infection induces the inhibition of harmful inflammatory responses, even with M1 polarization and activation of microglia and Th1 inflammatory responses, suggesting a host-parasite relationship through immune regulation during CI. This is a characteristic of infection immunity in infection with in the central nervous system, and SOCS1, a negative regulator of toxoplasmic encephalitis, may play a role in the increase in Arg1 levels to suppress NO production.

Citing Articles

Lactoferrin-modified nanoemulsions enhance brain-targeting and therapeutic efficacy of arctigenin against Toxoplasma gondii-induced neuronal injury.

Lu J, Jin G, Xin Y, Ma J, Shen X, Quan Y Int J Parasitol Drugs Drug Resist. 2024; 27():100575.

PMID: 39729771 PMC: 11733198. DOI: 10.1016/j.ijpddr.2024.100575.


macrophage migration inhibitory factor shows anti- potential via AZIN1/STAT1 interaction.

Yoon C, Kim H, Ham Y, Gil W, Mun S, Cho E Sci Adv. 2024; 10(43):eadq0101.

PMID: 39453997 PMC: 11506136. DOI: 10.1126/sciadv.adq0101.


Contrasting Disease Progression, Microglia Reactivity, Tolerance, and Resistance to Infection in Two Mouse Strains.

Diniz D, de Oliveira J, Guerreiro L, de Menezes G, de Assis A, Duarte T Biomedicines. 2024; 12(7).

PMID: 39061995 PMC: 11274029. DOI: 10.3390/biomedicines12071420.


Altered landscape of total RNA, tRNA and sncRNA modifications in the liver and spleen of mice infected by Toxoplasma gondii.

Zhang X, Sun Y, Wang W, Gao Y, Wei X, Sun H PLoS Negl Trop Dis. 2024; 18(6):e0012281.

PMID: 38905319 PMC: 11221703. DOI: 10.1371/journal.pntd.0012281.


Exploring the potential of Toxoplasma gondii in drug development and as a delivery system.

Yoon C, Ham Y, Gil W, Yang C Exp Mol Med. 2024; 56(2):289-300.

PMID: 38297164 PMC: 10907749. DOI: 10.1038/s12276-024-01165-7.


References
1.
Loke P, Allison J . PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A. 2003; 100(9):5336-41. PMC: 154346. DOI: 10.1073/pnas.0931259100. View

2.
Jankovic D, Kugler D, Sher A . IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010; 3(3):239-46. PMC: 4105209. DOI: 10.1038/mi.2010.8. View

3.
Denkers E . From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol. 2003; 39(3):193-203. DOI: 10.1016/S0928-8244(03)00279-7. View

4.
Kamerkar S, Davis P . Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection. J Parasitol Res. 2012; 2012:589295. PMC: 3321570. DOI: 10.1155/2012/589295. View

5.
Wohlfert E, Blader I, Wilson E . Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle. Trends Parasitol. 2017; 33(7):519-531. PMC: 5549945. DOI: 10.1016/j.pt.2017.04.001. View